It has been found that there was less expression of HIF-2α protein in normal tissues and organs but it was expressed in many tumor cells (such as endometrial cancer, bladder cancer, renal cell carcinoma, breast cancer, liver cancer, and prostate cancer cells) [12]. Here, EPAS1 is linked to prostate carcinoma.